The Medical Travel Company

The Medical Travel Company (TMTC) is a UK and India-based full-stack medical travel platform founded in 2024 by Sahil Jain and Ankit Mehrotra — the entrepreneurs behind Dineout, India's largest restaurant technology platform, which was acquired by Swiggy for $200 million in 2022. TMTC was built to address the structural failures of the global medical tourism industry, which processes an estimated $100 billion in annual volume but is characterised by fragmented care, hidden costs, and zero post-treatment support for patients who return home.

The platform targets UK patients who face deteriorating NHS access and increasingly long waiting lists — by mid-2025, over 7.7 million people were waiting for elective procedures — who want affordable, high-quality treatment in India at 60–70% lower cost than UK private rates. TMTC connects patients with treatment at globally accredited Indian hospitals (JCI and NABH certified), maintains UK doctor-led oversight throughout the entire journey, and provides personalised, all-inclusive aftercare. Its defining differentiator is the world's first 12-month post-surgery insurance policy valid in the UK at a network of private hospitals, covering complications that arise after the patient returns home.

The founders bring direct founder-market fit from their Dineout experience: building a consumer trust-driven platform across a historically fragmented industry with complex operational logistics. TMTC raised $4.5 million in seed funding in October 2025, led by Nexus Venture Partners, with participation from 4CAST — the athlete investment collective co-founded by England cricket captain Ben Stokes and fast bowler Jofra Archer. Angel investors include the co-founders of Swiggy, Tracxn, Innov8, Smile Group, and V3 Ventures.

TMTC was named to the Forbes India DGEMS 2025 Select 200 list of companies with strong global potential. The company plans to expand its model to the United States, Canada, Australia, and Europe within three to five years, using the UK-India corridor as the foundational proof of concept for scalable, trusted cross-border healthcare.